Vertex Analysts Lower Their Forecasts Following Q2 Results
Vertex raises annual revenue forecast on cystic fibrosis drugs strength
Nvidia, Vertex Pharmaceuticals And More On CNBC's ‘Final Trades'
Vertex Sees Over $5 Billion Peak Sales Potential From Crinetics Assets
Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion
Vertex to buy Crinetics in $10 billion deal
US FDA approves Vertex's gene therapy for sickle cell disease in children as young as two